Literature DB >> 16077736

Dimensional phenotypic analysis and functional categorisation of mutations reveal novel genotype-phenotype associations in Rett syndrome.

Tony Charman1, Tracey C S Neilson, Veronica Mash, Hayley Archer, Mary T Gardiner, Gun P S Knudsen, Aoibhinn McDonnell, Jacqueline Perry, Sharon D Whatley, David J Bunyan, Kirstine Ravn, Rebecca H Mount, Richard P Hastings, Maj Hulten, Karen Helene Orstavik, Sheena Reilly, Hilary Cass, Angus Clarke, Alison M Kerr, Mark E S Bailey.   

Abstract

We aimed to improve the understanding of genotype-phenotype correlations in Rett syndrome (RS) by adopting a novel approach to categorising phenotypic dimensions - separating typicality of presentation, outcome severity and age of onset - and by classifying MECP2 mutations strictly by predicted functional attributes. MECP2 mutation screening results were available on 190 patients with a clinical diagnosis of RS (140 cases with classic RS, 50 with atypical RS). 135 cases had identified mutations. Of the 140 patients, 116 with classic RS (82.9%) had an identified mutation compared with 19 of 50 patients (38%) with an atypical presentation. Cases with early onset of regression and seizures, and those with clinical features that might indicate alternative aetiologies, were less likely to have mutations. Individuals with late truncating mutations had a less typical presentation than cases with missense and early truncating mutations, presumably reflecting greater residual function of MECP2 protein. Individuals with early truncating mutations had a more severe outcome than cases with missense and late truncating mutations. These findings held when restricting the analysis to cases over 15 years of age and classic cases only. Previous findings of variation in severity among the common mutations were confirmed. The approach to phenotypic and genotypic classification adopted here allowed us to identify genotype-phenotype associations in RS that may aid our understanding of pathogenesis and also contribute to clinical knowledge on the impact of different types of mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077736     DOI: 10.1038/sj.ejhg.5201471

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  18 in total

1.  Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation.

Authors:  Hayley Archer; Julie Evans; Helen Leonard; Lyn Colvin; David Ravine; John Christodoulou; Sarah Williamson; Tony Charman; Mark E S Bailey; Julian Sampson; Nicholas de Klerk; Angus Clarke
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

2.  Development of a video-based evaluation tool in Rett syndrome.

Authors:  S Fyfe; J Downs; O McIlroy; B Burford; J Lister; S Reilly; C L Laurvick; C Philippe; M Msall; W E Kaufmann; C Ellaway; H Leonard
Journal:  J Autism Dev Disord       Date:  2006-12-16

3.  Variant Profile of MECP2 Gene in Sri Lankan Patients with Rett Syndrome.

Authors:  D Hettiarachchi; N F Neththikumara; B A P S Pathirana; V H W Dissanayake
Journal:  J Autism Dev Disord       Date:  2020-01

4.  Atypical presentations and specific genotypes are associated with a delay in diagnosis in females with Rett syndrome.

Authors:  Stephanie Fehr; Jenny Downs; Ami Bebbington; Helen Leonard
Journal:  Am J Med Genet A       Date:  2010-10       Impact factor: 2.802

5.  NTNG1 mutations are a rare cause of Rett syndrome.

Authors:  Hayley L Archer; Julie C Evans; David S Millar; Peter W Thompson; Alison M Kerr; Helen Leonard; John Christodoulou; David Ravine; Lazarus Lazarou; Lucy Grove; Christopher Verity; Sharon D Whatley; Daniela T Pilz; Julian R Sampson; Angus J Clarke
Journal:  Am J Med Genet A       Date:  2006-04-01       Impact factor: 2.802

6.  Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome.

Authors:  Vishnu Anand Cuddapah; Rajesh B Pillai; Kiran V Shekar; Jane B Lane; Kathleen J Motil; Steven A Skinner; Daniel Charles Tarquinio; Daniel G Glaze; Gerald McGwin; Walter E Kaufmann; Alan K Percy; Jeffrey L Neul; Michelle L Olsen
Journal:  J Med Genet       Date:  2014-01-07       Impact factor: 6.318

7.  A novel hypomorphic MECP2 point mutation is associated with a neuropsychiatric phenotype.

Authors:  Abidemi A Adegbola; Michael L Gonzales; Andrew Chess; Janine M LaSalle; Gerald F Cox
Journal:  Hum Genet       Date:  2008-11-07       Impact factor: 4.132

Review 8.  Autism-lessons from the X chromosome.

Authors:  Elysa J Marco; David H Skuse
Journal:  Soc Cogn Affect Neurosci       Date:  2006-12       Impact factor: 3.436

9.  Diurnal variation in autonomic regulation among patients with genotyped Rett syndrome.

Authors:  Michael Sean Carroll; Jan-Marino Ramirez; Debra E Weese-Mayer
Journal:  J Med Genet       Date:  2020-03-10       Impact factor: 6.318

10.  InterRett, a model for international data collection in a rare genetic disorder.

Authors:  Sandra Louise; Sue Fyfe; Ami Bebbington; Nadia Bahi-Buisson; Alison Anderson; Mercé Pineda; Alan Percy; Bruria Ben Zeev; Xi Ru Wu; Xinhua Bao; Patrick Mac Leod; Judith Armstrong; Helen Leonard
Journal:  Res Autism Spectr Disord       Date:  2009-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.